Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/76864
Campo DC Valoridioma
dc.contributor.authorLosa García, J. E.en_US
dc.contributor.authorRodríguez, F. M.en_US
dc.contributor.authorMartín de Cabo, M. R.en_US
dc.contributor.authorGarcía Salgado, M. J.en_US
dc.contributor.authorLosada, J. P.en_US
dc.contributor.authorVillarón, L. G.en_US
dc.contributor.authorLópez, A. J.en_US
dc.contributor.authorPérez Arellano, José Luisen_US
dc.date.accessioned2020-12-20T19:06:21Z-
dc.date.available2020-12-20T19:06:21Z-
dc.date.issued1999en_US
dc.identifier.issn0962-9351en_US
dc.identifier.otherWoS-
dc.identifier.urihttp://hdl.handle.net/10553/76864-
dc.description.abstractThe alveolar macrophage (AM) secretes interleukin 1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) and interleukin-8 (IL-8), all of them inflammatory cytokines involved in the pathogenesis of many lung diseases. The aim of the present work was to evaluate the basal and stimulated secretion of these cytokines by human AMs. Human AMs were collected by bronchoalveolar lavage (BAL) from four healthy controls and 13 patients with diffuse interstitial lung disease (five cases of sarcoidosis, three of hypersensitivity pneumonitis and five of idiopathic pulmonary fibrosis). AMs were cultured in the presence or absence of different concentrations of lipopolysaccharide (LPS), phorbolmyristate and gamma-interferon. IL-1 beta, TNF-alpha, IL-6 and IL-8 levels were measured in BAL fluid and culture supernatant using specific enzyme-linked immunosorbent assays. The substance found to stimulate the secretion of inflammatory cytokines to the greatest extent was LPS at a concentration of 10 mu g/ml. Regarding the secretion of IL-1 beta, four observations were of interest: basal secretion was very low; LPS exerted a potent stimulatory effect; considerable within-group variability was observed; and there were no significant differences in the comparisons among groups. With respect to TNF-alpha secretion, the results were similar. The only striking finding was the higher basal secretion of this cytokine with respect to that of IL-1 beta. Regarding the secretion of IL-6, the same pattern followed by TNF-alpha was found. However it should be stressed that the increase induced by LPS was smaller than in the two previous cytokines. Regarding the secretion of IL-8, three findings were patent: the strong basal secretion of this cytokine; the moderate increase induced by LPS; and the existence of significant differences among the different groups with respect to the stimulated secretion of this cytokine, which reached maximum values in patients with idiopathic pulmonary fibrosis. Finally, it should be noted that the pattern of cytokines observed in the BAL fluid was similar to that found in cultured AM supernatants. The pattern of inflammatory cytokine secretion by AMs differs from that of other cells of the mononuclear phagocyte system (MPS). In this sense. AMs secrete low amounts of IL-1, moderate amounts of TNF-alpha and IL-6, and high quantities of IL-8. Adherence is an important stimulus in the secretion of these molecules and LPS elicits an increased secretion inverse to the basal secretion. There is considerable individual variability in the secretion of inflammatory cytokines by the AMs of patients with interstitial lung disease and the AMs of these patients are primed in vivo for the secretion of these cytokines. The results of our study, carried out in vitro, can be extrapolated to the in vivo setting.en_US
dc.languageengen_US
dc.relation.ispartofMediators of Inflammationen_US
dc.sourceMediators of Inflammation [ISSN 0962-9351], v. 8 (1), p. 43-51, (1999)en_US
dc.subject3202 Epidemologiaen_US
dc.subject.otherAlveolar Macrophageen_US
dc.subject.otherTumour Necrosis Factoren_US
dc.subject.otherInterleukin-1en_US
dc.subject.otherInterleukin-6en_US
dc.subject.otherInterleukin-8en_US
dc.titleEvaluation of inflammatory cytokine secretion by human alveolar macrophagesen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.isi000079969200008-
dc.description.lastpage51en_US
dc.identifier.issue1-
dc.description.firstpage43en_US
dc.relation.volume8en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid5433912-
dc.contributor.daisngid27721736-
dc.contributor.daisngid8187598-
dc.contributor.daisngid1344566-
dc.contributor.daisngid5615497-
dc.contributor.daisngid2287316-
dc.contributor.daisngid4074210-
dc.contributor.daisngid445671-
dc.description.numberofpages9en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Garcia, JEL-
dc.contributor.wosstandardWOS:Rodriguez, FM-
dc.contributor.wosstandardWOS:de Cabo, MRM-
dc.contributor.wosstandardWOS:Salgado, MJG-
dc.contributor.wosstandardWOS:Losada, JP-
dc.contributor.wosstandardWOS:Villaron, LG-
dc.contributor.wosstandardWOS:Lopez, AJ-
dc.contributor.wosstandardWOS:Arellano, JLP-
dc.date.coverdate1999en_US
dc.identifier.ulpgcen_US
dc.description.jcr0,711
dc.description.jcrqQ4
dc.description.scieSCIE
item.grantfulltextopen-
item.fulltextCon texto completo-
crisitem.author.deptGIR IUIBS: Trypanosomosis, Resistencia a Antibióticos y Medicina Animal-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2936-8242-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNamePérez Arellano, José Luis-
Colección:Artículos
miniatura
pdf
Adobe PDF (207,8 kB)
Vista resumida

Citas de WEB OF SCIENCETM
Citations

65
actualizado el 25-feb-2024

Visitas

71
actualizado el 06-ene-2024

Descargas

42
actualizado el 06-ene-2024

Google ScholarTM

Verifica


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.